The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter
Authors:
- Jennifer L BartonJBJennifer L Barton
- Christopher J KoenigCKChristopher J Koenig
- Gina Evans-YoungGEGina Evans-Young
- Laura TrupinLTLaura Trupin
- Jennie AndersonJAJennie Anderson
- Dana RagouzeosDRDana Ragouzeos
- Maggie BreslinMBMaggie Breslin
- Timothy MorseTMTimothy Morse
- Dean SchillingerDSDean Schillinger
- Victor M MontoriVMVictor M Montori
- Edward H YelinEYEdward H Yelin
Open Access
- 25 November 2014
- journal article
- research article
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 14 (1) , 104
Abstract
Shared decision-making in rheumatoid arthritis (RA) care is a priority among policy makers, clinicians and patients both nationally and internationally. Demands on patients to have basic knowledge of RA, treatment options, and details of risk and benefit when making medication decisions with clinicians can be overwhelming, especially for those with limited literacy or limited English language proficiency. The objective of this study is to describe the development of a medication choice decision aid for patients with rheumatoid arthritis (RA) in three languages using low literacy principles. Based on the development of a diabetes decision aid, the RA decision aid (RA Choice) was developed through a collaborative process involving patients, clinicians, designers, decision-aid and health literacy experts. A combination of evidence synthesis and direct observation of clinician-patient interactions generated content and guided an iterative process of prototype development. Three iterations of RA Choice were developed and field-tested before completion. The final tool organized data using icons and plain language for 12 RA medications across 5 issues: frequency of administration, time to onset, cost, side effects, and special considerations. The tool successfully created a conversation between clinician and patient, and garnered high acceptability from clinicians. The process of collaboratively developing an RA decision aid designed to promote shared decision making resulted in a graphically-enhanced, low literacy tool. The use of RA Choice in the clinical encounter has the potential to enhance communication for RA patients, including those with limited health literacy and limited English language proficiency.Keywords
This publication has 42 references indexed in Scilit:
- Uncovering the Benefits of Participatory Research: Implications of a Realist Review for Health Research and PracticeThe Milbank Quarterly, 2012
- Helping Patients Decide: Ten Steps to Better Risk CommunicationJNCI: Journal of the National Cancer Institute, 2011
- Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university‐affiliated clinicsArthritis Care & Research, 2011
- Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics RegisterAnnals of the Rheumatic Diseases, 2011
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnnals of the Rheumatic Diseases, 2010
- Treating rheumatoid arthritis to target: recommendations of an international task forceAnnals of the Rheumatic Diseases, 2010
- Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysisAnnals of the Rheumatic Diseases, 2009
- Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E InitiativeAnnals of the Rheumatic Diseases, 2009
- Racial Disparities in Treatment Preferences for Rheumatoid ArthritisMedical Care, 2009
- The impact of patient‐perceived restricted access to anti‐TNF therapy for rheumatoid arthritis: a qualitative studyMusculoskeletal Care, 2009